The delivery device and drug form should be considered when choosing a test method for identifying and measuring particulates in inhaled drug products. Orally inhaled and nasal drug products (OINDPs) ...

Patients are administered parenteral drugs usually by means of injections, and therefore these drugs must be free of visible particles. To ensure this, the USP <788> Particulate Matter in Injections ...

STEMart, a US-based provider of comprehensive services for all phases of medical device development, is proud to announce the launch of its new Particulate Matter Testing Services, offering a wide ...

Cleviprex injection recalled due to presence of particulate matter The FDA and The Medicines Company have notified healthcare professionals of a voluntary nationwide recall of 11 lots of Cleviprex ...

Light obscuration testing is the preferred method of sub-visible particle quantification but is not suitable for every preparation. Particulate matter by light obscuration (LO) testing quantifies ...

Lundbeck Inc. has voluntarily recalled two lots of NeoProfen (ibuprofen lysine) injection that failed to meet a visible particulate quality requirement. These two lots are the only lots currently ...

Editor's note: Industry Insights are sponsored blogs submitted by manufacturers and suppliers serving the fire service industry. In addition to traditional hoods, the 2018 edition of the NFPA 1971 ...

The solution to characterizing particle scattering as a function of UV/Visible spectroscopy is found in the Rayleigh scattering equation represented in Equation 1. Shown below is the generalized form ...

STEMart now offers Particulate Matter Testing Services with a range of particulate matter testing from <0.001 μm to >3,000 μm. The team of experts can provide accurate analysis and material ...